DRKS00009348已完成不适用
Overexpression of CXCR4, CXCL12 and CXCR7 as a therapeutic approach to restore sensitivity to novel agents in multiple myeloma. - CXCR4
niklinik Freiburg0 个研究点目标入组 130 人开始时间: 2015年10月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients with multiple myeloma.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
CHEMOKINE RECEPTOR CXCR4-DIRECTED THERANOSTICS OF ADVANCED LYMPHOPROLIFERATIVE CANCERS BY RADIOPEPTIDE-BASED IMAGING AND THERAPY:THE COLPRIT PHASE I/II STUDYIndication: Non-Hodgkin lymphomas (NHL)Advanced lymphoproliferative cancers: aggressive B- and T- cell Non-Hodgkin lymphomas (NHL), including heavily pretreated transformed indolent lymphoma (tNHL) and multiple myeloma (MM) as a subgroup of B-cell NHLMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2022-002989-33-DEKlinikum rechts der Isar der Technischen Universität München38
进行中（未招募）
不适用
A study of the efficacy of POL6326 in treating patients following a heart attackMedDRA version: 18.0Level: LLTClassification code 10064345Term: ST segment elevation myocardial infarctionSystem Organ Class: 100000004849Acute Myocardial InfarctionEUCTR2012-003229-91-HUPolyphor AG140
进行中（未招募）
不适用
A study of the efficacy of POL6326 in treating patients following a heart attackAcute Myocardial InfarctionEUCTR2012-003229-91-DEPolyphor AG140
进行中（未招募）
不适用
A study of the efficacy of POL6326 in treating patients following a heart attackAcute Myocardial InfarctionEUCTR2012-003229-91-PLPolyphor AG140
进行中（未招募）
不适用
A study of the efficacy of POL6326 in treating patients following a heart attackAcute Myocardial InfarctionEUCTR2012-003229-91-HRPolyphor AG140